Arctoris

Upload virtual hit list (SMILES) to Arctoris portal.

Select validated biochemical assay from the Ulysses library.

Robots execute testing across multiple concentrations.

Receive validated binding affinity data within 48-72 hours.

Integrate lead optimization ML model with Arctoris API.

Model proposes new analogs based on previous results.

Arctoris robots synthesize (via partners) and test analogs.

Results are fed back into the model autonomously for the next iteration.

Run candidate molecules against a panel of human cell lines.

Monitor cellular health and morphology using high-content imaging.

Analyze off-target effects using automated secondary assays.

Identify high-risk candidates before entering clinical trials.

Configure Ulysses for time-resolved fluorescence energy transfer (TR-FRET).

Conduct continuous monitoring of protein degradation over 24 hours.

Extract kinetic parameters (Dmax, DC50) via automated analysis.

Use data to refine degradation efficacy models.

Digitize internal proprietary protocols onto the Ulysses platform.

Centralize all experimental execution in the Arctoris robotic hub.

Ensure every scientist gets identical data quality regardless of location.

Store all data in a unified, searchable corporate database.

Outsource the entire physical assay layer to Arctoris.

Utilize Arctoris's pre-validated target libraries.

Conduct screenings on a 'pay-as-you-go' basis.

Retain all IP while minimizing overhead costs.

Generate all required pharmacology data using automated robotic runs.

Export standardized, timestamped reports with full audit logs.

Attach robotic environmental telemetry as proof of assay stability.

Submit high-fidelity data packages to regulatory bodies (FDA/EMA).